Mitral valve-in-valve and valve-in-ring procedures: Midterm outcomes in a French nationwide registry.
Robin Le RuzPatrice GuérinGuillaume LeurentLionel LerouxThierry LefevreMohammed NejjariDidier ChampagnacDidier TchétchéThibault LhermusierThomas SenagePierre-Guillaume PiriouChristophe CaussinMaxence DelomezGuillaume BonnetXavier FavereauNicole KaramAntoine GerbayFrancis JuthierMartine GilardJean-Francois ObadiaBernard IungThibaut ManigoldPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2022)
This study confirms the safety and efficacy of the mitral ViV procedure. ViR patients appear at higher risk of procedural complications. The presence of PVL could be associated with markedly worse midterm prognosis. Whatever the intervention, procedural strategies to reduce PVL incidence remain to be assessed to prevent latter adverse outcomes.
Keyphrases
- mitral valve
- left atrial
- end stage renal disease
- ejection fraction
- aortic stenosis
- left ventricular
- risk factors
- randomized controlled trial
- newly diagnosed
- aortic valve
- chronic kidney disease
- prognostic factors
- type diabetes
- minimally invasive
- peritoneal dialysis
- adipose tissue
- coronary artery disease
- metabolic syndrome
- skeletal muscle
- cross sectional